Zanubrutinib potentiates polatuzumab vedotin efficacy in DLBCL with concurrent CD79b upregulation. [PDF]
Zhou X +12 more
europepmc +1 more source
Durability Benchmarking of Contemporary Second-Line and Later Therapies for Relapsed or Refractory Follicular Lymphoma Using Reconstructed Individual Patient Data From Published Kaplan-Meier Curves. [PDF]
Burke OJ +3 more
europepmc +1 more source
Case Report: Frontline CD19 CAR-T-cell therapy combined with targeted regimens induces durable complete remission in newly diagnosed secondary CNS lymphoma: a report of two cases. [PDF]
Pan Q +8 more
europepmc +1 more source
Sequential Bilateral Optic Neuropathy Associated With IgM-Secreting B-cell Non-Hodgkin Lymphoma. [PDF]
Kang MJ +4 more
europepmc +1 more source
Case Report: Discordant diffuse large B-cell lymphoma and splenic peripheral T-cell lymphoma revealed by persistent splenomegaly and cytopenia. [PDF]
Ruan Z, Fan G, Xu L.
europepmc +1 more source
Phase 1 study of zanubrutinib plus lenalidomide for patients with relapsed/refractory diffuse large B-cell lymphoma. [PDF]
Song Z +15 more
europepmc +1 more source
Continuous or fixed-duration BTK inhibitor treatment for WM. [PDF]
Yi S, Qiu L.
europepmc +1 more source
Successful Treatment of Evans Syndrome Onset With Zanubrutinib in Combination With Romiplostim During Venetoclax Treatment in a Patient With Chronic Lymphocytic Leukemia: A Case Report. [PDF]
Innao V +4 more
europepmc +1 more source
Recurrence of B-cell Lymphoma Manifesting as Progressive Peripheral and Cranial Nerve Neuropathies: A Case Report. [PDF]
Schofield S +3 more
europepmc +1 more source

